Deborah H. Anderson

Prince Albert, SK, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

2-methoxyestradiol is effective in 2D and 3D models of NCI-H2170 lung squamous cell carcinoma cells.

2-methoxyestradiol is effective in 2D and 3D models of NCI-H2170 lung squamous cell carcinoma cells.

Journal: PloS one

Published: May 26, 2026

CLIC3 is upregulated across all subtypes of breast cancer and plays a key role in cell migration, invasion and growth in soft agar.

CLIC3 is upregulated across all subtypes of breast cancer and plays a key role in cell migration, invasion and growth in soft agar.

Journal: Breast cancer research : BCR

Published: November 12, 2025

Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells.

Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 06, 2025

Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel.

Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel.

Journal: Scientific reports

Published: May 03, 2022

Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product.

Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product.

Journal: Clinical pharmacology and therapeutics

Published: November 08, 2021

Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.

Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.

Journal: PloS one

Published: June 14, 2021

Impact of p85α Alterations in Cancer.

Impact of p85α Alterations in Cancer.

Journal: Biomolecules

Published: December 07, 2018

Insight into the PTEN - p85α interaction and lipid binding properties of the p85α BH domain.

Insight into the PTEN - p85α interaction and lipid binding properties of the p85α BH domain.

Journal: Oncotarget

Published: August 09, 2018

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.

Journal: BMC cancer

Published: June 18, 2018

Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.

Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.

Journal: Scientific reports

Published: January 18, 2018

Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase.

Identification of the Binding Sites on Rab5 and p110beta Phosphatidylinositol 3-kinase.

Journal: Scientific reports

Published: June 30, 2017

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Journal: Oncogene

Published: May 17, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026